182 related articles for article (PubMed ID: 35666111)
1. Quantifying concordant genetic effects of de novo mutations on multiple disorders.
Guo H; Hou L; Shi Y; Jin SC; Zeng X; Li B; Lifton RP; Brueckner M; Zhao H; Lu Q
Elife; 2022 Jun; 11():. PubMed ID: 35666111
[TBL] [Abstract][Full Text] [Related]
2. Analysis workflow to assess
Diab NS; King S; Dong W; Allington G; Sheth A; Peters ST; Kahle KT; Jin SC
STAR Protoc; 2021 Mar; 2(1):100383. PubMed ID: 33748785
[TBL] [Abstract][Full Text] [Related]
3. Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database.
Li J; Cai T; Jiang Y; Chen H; He X; Chen C; Li X; Shao Q; Ran X; Li Z; Xia K; Liu C; Sun ZS; Wu J
Mol Psychiatry; 2016 Feb; 21(2):290-7. PubMed ID: 25849321
[TBL] [Abstract][Full Text] [Related]
4. Identification of De Novo DNMT3A Mutations That Cause West Syndrome by Using Whole-Exome Sequencing.
Liu Z; Li Z; Zhi X; Du Y; Lin Z; Wu J
Mol Neurobiol; 2018 Mar; 55(3):2483-2493. PubMed ID: 28386848
[TBL] [Abstract][Full Text] [Related]
5. [Exploring the association between
Chen X; Wang SY; Xue EC; Wang XH; Peng HX; Fan M; Wang MY; Wu YQ; Qin XY; Li J; Wu T; Zhu HP; Li J; Zhou ZB; Chen DF; Hu YH
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 54(3):387-393. PubMed ID: 35701113
[TBL] [Abstract][Full Text] [Related]
6. A Statistical Framework for Mapping Risk Genes from De Novo Mutations in Whole-Genome-Sequencing Studies.
Liu Y; Liang Y; Cicek AE; Li Z; Li J; Muhle RA; Krenzer M; Mei Y; Wang Y; Knoblauch N; Morrison J; Zhao S; Jiang Y; Geller E; Ionita-Laza I; Wu J; Xia K; Noonan JP; Sun ZS; He X
Am J Hum Genet; 2018 Jun; 102(6):1031-1047. PubMed ID: 29754769
[TBL] [Abstract][Full Text] [Related]
7. Exome sequencing in schizophrenia-affected parent-offspring trios reveals risk conferred by protein-coding de novo mutations.
Howrigan DP; Rose SA; Samocha KE; Fromer M; Cerrato F; Chen WJ; Churchhouse C; Chambert K; Chandler SD; Daly MJ; Dumont A; Genovese G; Hwu HG; Laird N; Kosmicki JA; Moran JL; Roe C; Singh T; Wang SH; Faraone SV; Glatt SJ; McCarroll SA; Tsuang M; Neale BM
Nat Neurosci; 2020 Feb; 23(2):185-193. PubMed ID: 31932770
[TBL] [Abstract][Full Text] [Related]
8. Gene4Denovo: an integrated database and analytic platform for de novo mutations in humans.
Zhao G; Li K; Li B; Wang Z; Fang Z; Wang X; Zhang Y; Luo T; Zhou Q; Wang L; Xie Y; Wang Y; Chen Q; Xia L; Tang Y; Tang B; Xia K; Li J
Nucleic Acids Res; 2020 Jan; 48(D1):D913-D926. PubMed ID: 31642496
[TBL] [Abstract][Full Text] [Related]
9. Identification of de novo germline mutations and causal genes for sporadic diseases using trio-based whole-exome/genome sequencing.
Jin ZB; Li Z; Liu Z; Jiang Y; Cai XB; Wu J
Biol Rev Camb Philos Soc; 2018 May; 93(2):1014-1031. PubMed ID: 29154454
[TBL] [Abstract][Full Text] [Related]
10. A novel
Singh AK; Viviano S; Allington G; McGee S; Kiziltug E; Mekbib KY; Shohfi JP; Duy PQ; DeSpenza T; Furey CG; Reeves BC; Smith H; Ma S; Sousa AMM; Cherskov A; Allocco A; Nelson-Williams C; Haider S; Rizvi SRA; Alper SL; Sestan N; Shimelis H; Walsh LK; Lifton RP; Moreno-De-Luca A; Jin SC; Kruszka P; Deniz E; Kahle KT
medRxiv; 2023 Mar; ():. PubMed ID: 36993720
[TBL] [Abstract][Full Text] [Related]
11. mTADA is a framework for identifying risk genes from de novo mutations in multiple traits.
Nguyen TH; Dobbyn A; Brown RC; Riley BP; Buxbaum JD; Pinto D; Purcell SM; Sullivan PF; He X; Stahl EA
Nat Commun; 2020 Jun; 11(1):2929. PubMed ID: 32522981
[TBL] [Abstract][Full Text] [Related]
12. A de novo pathogenic CSNK1E mutation identified by exome sequencing in family trios with epileptic encephalopathy.
Chen X; Jin J; Wang Q; Xue H; Zhang N; Du Y; Zhang T; Zhang B; Wu J; Liu Z
Hum Mutat; 2019 Mar; 40(3):281-287. PubMed ID: 30488659
[TBL] [Abstract][Full Text] [Related]
13. Whole exome sequencing coupled with unbiased functional analysis reveals new Hirschsprung disease genes.
Gui H; Schriemer D; Cheng WW; Chauhan RK; Antiňolo G; Berrios C; Bleda M; Brooks AS; Brouwer RW; Burns AJ; Cherny SS; Dopazo J; Eggen BJ; Griseri P; Jalloh B; Le TL; Lui VC; Luzón-Toro B; Matera I; Ngan ES; Pelet A; Ruiz-Ferrer M; Sham PC; Shepherd IT; So MT; Sribudiani Y; Tang CS; van den Hout MC; van der Linde HC; van Ham TJ; van IJcken WF; Verheij JB; Amiel J; Borrego S; Ceccherini I; Chakravarti A; Lyonnet S; Tam PK; Garcia-Barceló MM; Hofstra RM
Genome Biol; 2017 Mar; 18(1):48. PubMed ID: 28274275
[TBL] [Abstract][Full Text] [Related]
14. Second-tier trio exome sequencing after negative solo clinical exome sequencing: an efficient strategy to increase diagnostic yield and decipher molecular bases in undiagnosed developmental disorders.
Tran Mau-Them F; Moutton S; Racine C; Vitobello A; Bruel AL; Nambot S; Kushner SA; de Vrij FMS; Lehalle D; Jean-Marçais N; Lecoquierre F; Delanne J; Thevenon J; Poe C; Jouan T; Chevarin M; Geneviève D; Willems M; Coubes C; Houcinat N; Masurel-Paulet A; Mosca-Boidron AL; Tisserant E; Callier P; Sorlin A; Duffourd Y; Faivre L; Philippe C; Thauvin-Robinet C
Hum Genet; 2020 Nov; 139(11):1381-1390. PubMed ID: 32399599
[TBL] [Abstract][Full Text] [Related]
15. The contribution of whole-exome sequencing to intellectual disability diagnosis and knowledge of underlying molecular mechanisms: A systematic review and meta-analysis.
Sánchez-Luquez KY; Carpena MX; Karam SM; Tovo-Rodrigues L
Mutat Res Rev Mutat Res; 2022; 790():108428. PubMed ID: 35905832
[TBL] [Abstract][Full Text] [Related]
16. Sex-Based Analysis of De Novo Variants in Neurodevelopmental Disorders.
Turner TN; Wilfert AB; Bakken TE; Bernier RA; Pepper MR; Zhang Z; Torene RI; Retterer K; Eichler EE
Am J Hum Genet; 2019 Dec; 105(6):1274-1285. PubMed ID: 31785789
[TBL] [Abstract][Full Text] [Related]
17. Whole-exome DNA sequencing in childhood anxiety disorders identifies rare de novo damaging coding variants.
Olfson E; Lebowitz ER; Hommel G; Pashankar N; Silverman WK; Fernandez TV
Depress Anxiety; 2022 Jun; 39(6):474-484. PubMed ID: 35312124
[TBL] [Abstract][Full Text] [Related]
18. DeNovoCNN: a deep learning approach to de novo variant calling in next generation sequencing data.
Khazeeva G; Sablauskas K; van der Sanden B; Steyaert W; Kwint M; Rots D; Hinne M; van Gerven M; Yntema H; Vissers L; Gilissen C
Nucleic Acids Res; 2022 Sep; 50(17):e97. PubMed ID: 35713566
[TBL] [Abstract][Full Text] [Related]
19. Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutations.
Kataoka M; Matoba N; Sawada T; Kazuno AA; Ishiwata M; Fujii K; Matsuo K; Takata A; Kato T
Mol Psychiatry; 2016 Jul; 21(7):885-93. PubMed ID: 27217147
[TBL] [Abstract][Full Text] [Related]
20. Whole Exome Sequencing Identifies Novel De Novo Variants Interacting with Six Gene Networks in Autism Spectrum Disorder.
Kim N; Kim KH; Lim WJ; Kim J; Kim SA; Yoo HJ
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
